Identification and expression analysis of the immunosuppressive molecule of endometrial cancer
| Project/Area Number |
22791544
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Obstetrics and gynecology
|
|---|
| Research Institution | Keio University |
|---|
Principal Investigator |
HIRAO Nobumaru 慶應義塾大学, 医学部, 共同研究員 (80327593)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 子宮体癌 / 免疫抑制 / MYEOV / 免疫応答 / 免疫逃避 / B7-タンパ |
|---|
| Research Abstract |
Myeloma overexpressed gene (MYEOV) was identified as a potential cancer antigen that was expressed frequently in cancer tissues. A high expression level of MYEOV was positively correlated with deep myometrial invasion and negatively correlated with diseas
|
Report
(4 results)
Research Products
(3 results)
-
[Journal Article] Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.2012
Author(s)
Okabayashi K, Fujita T, Miyazaki J, Okada T, Iwata T, Hirao N, Noji S, Tsukamoto N, Goshima N, Hasegawa H, Takeuchi H, Ueda M, Kitagawa Y, Kawakami Y.
-
Journal Title
Cancer Sci
Volume: 103(9)
Issue: 9
Pages: 1617-24
DOI
Related Report
Peer Reviewed
-
-
